Neusoft IntelliRay Technology Co., Ltd, a medical technology company based in Shenyang, has successfully closed a Series C funding round, securing over RMB 100 million (approximately USD 13.8 million). The financing was spearheaded by Leli PE Capital and Neusoft Capital, with the funds earmarked for the advancement and market expansion of IntelliRay’s high-end radiotherapy equipment and associated information systems, as well as the establishment of new industrial facilities.
Established in 2018, Neusoft IntelliRay specializes in the innovation of state-of-the-art medical linear accelerators and tumor radiotherapy information systems. The company is at the forefront of integrating artificial intelligence (AI) and cloud computing technologies into radiotherapy, aiming to enhance treatment efficacy and precision. NeuRT Aurora, the company’s flagship product, represents a significant leap in domestic radiotherapy capabilities.- Flcube.com
